Quote:

---

Have I correctly interpreted today's company statement to say that we are having a seriiusly difficult time selling warrants and are in serious danger of downsizing or eliminating clinical trial plans going forward which may put the company's future in jeopardy?

---

The structure of the original warrant exercise plan was not entirely enticing. Exercising for 30% below current share price and additional warrants is much better than just 30% below. It was stated in the amended plan that the money would be used for the CRC trial and other expenses.